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HIGHLY SELECTIVE MMP-13 INHIBITOR PREVENTS
COLLAGEN DEGRADATION IN HUMAN OA CARTILAGE
D. Piecha1, G. Becher1, J. Boer1, H. Kheil1, T. Powers2,
A. Taveras2, A. Timmermann1, J. VanVeldhuizen2, J. Weik1,
M. Hofmann1
1Alantos Pharmaceuticals, Heidelberg, Germany, 2Alantos
Pharmaceuticals, Cambridge, MA
Purpose: Matrix metalloproteinases (MMPs) have long been
considered as excellent targets for the treatment of osteoarthritis
(OA). However, realization of this concept has been hampered
by dose-limiting musculoskeletal side effects observed in hu-
mans with broad spectrum inhibitors. MMP-13, the major type
II collagenase, is highly up-regulated in OA/RA and therefore
strongly implicated in the pathogenesis of OA. Selective inhibi-
tion of MMP-13 may provide the desired cartilage degradation
protection while overcoming the musculoskeletal toxicity seen by
non-selective inhibition of MMPs.
Methods: Selectivity determination. Kinetic studies. Culture of
bovine and human cartilage explants.
Results: We have identified a new class of very potent and
highly selective MMP-13 inhibitors which showed no activity
against other MMPs, TACE or members of the ADAMTS fam-
ily at concentrations up to 20μM. Kinetic studies specified this
class of compounds as mixed-type, non-zinc binding inhibitors.
Excessive cleavage of type II collagen is a fundamental patho-
logical feature of OA. In cultured explants from OA patients,
collagen degradation was significantly reduced by the selective
MMP-13 inhibitor. Inhibition of collagen degradation was studied
in bovine and human articular cartilage systems, where the carti-
lage degradation was induced by the addition of pro-inflammatory
cytokines IL-1a and oncostatin M. Our highly selective MMP-13
inhibitors completely blocked type II collagen degradation in
bovine explants and showed up to 80% inhibition in human OA
cartilage, while proteoglycan degradation remained unchanged.
These results were confirmed with different biomarkers (C1,2C,
C2C, CTX-II) and hydroxyproline determination which validates
MMP-13 as the primary collagenase in the IL-1/OSM-induced
cartilage degradation process.
Conclusions: Our results emphasize the role of MMP-13 in
pathologic cartilage degradation and verify the value of selective
MMP-13 inhibitors for potential treatment of OA and RA.
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HOW DOES VITAMIN D AFFECT BONE AND CARTILAGE
IN A GUINEA PIG MODEL OF OSTEOARTHRITIS?
T. Hunt1, R. Kandel2, R. Renlund2, R. Vieth2, M. Grynpas1
1Samuel Lunenfeld Research Institute, Mount Sinai Hospital,
Toronto, ON, Canada, 2Department of Laboratory Medicine and
Pathobiology, University of Toronto, Toronto, ON, Canada
Purpose: Clinical studies have shown that changes in bone are
important determinants for the progression of OA and vitamin D
is known to promote bone health. We wish to determine whether
vitamin D supplementation produces any beneficial or detrimen-
tal effects in cartilage and in subchondral bone in Guinea Pig
model of OA.
Methods: Male Dunkin-Hartley guinea pigs spontaneously ac-
quire OA because of a rapid weight increase and by performing
a full lateral menisectomy (MNX) the OA becomes accelerated
and predictable. The MNX was performed on the left leg, right
leg acting as an internal control. Groups of 8 male MNX guinea
pigs will be followed for 1, 3 and 6 months to evaluate the effect
of vitamin D on bone and cartilage. In each time point there are 3
groups; no vitamin D (NVD), control (NT) and high dose vitamin
D (HVD). The NVD group was fed a diet consisting of no vita-
min D, the NT group was fed a normal diet with 153IU/day and
the HVD group was fed an extra 380IU/day. Guinea pigs were
received at 2 months of age; vitamin D treatment was started
upon arrival. After 1 month of acclimatization the MNX was per-
formed and the animals were sacrificed 1, 3 and 6 months after
MNX. To define the response of cartilage to vitamin D sections
of the tibia were stained using Safranin-O and a fast green
counter stain to be evaluated using a modified Mankin grad-
ing. Bone mineral density (BMD) was evaluated using DEXA,
and bone histomorphometric parameters were evaluated using
Bioquant software. Vitamin D serum levels and tissue calcium
accumulation were also investigated. Subchondral bone quality
will be determined including image analysis to determine bone
connectivity, backscattered electron imaging to determine bone
mineralization and micro-hardness to determine stiffness.
Results: Preliminary results for 1 and 3 month time points show
that 1 month after surgery a significant (p<0.05) increase was
seen between treatment groups for blood serum vitamin D levels.
The 1 month BMD showed a significant decrease in the MNX
leg compared to the control in each group (NVD-6.5%; NT-9.4%;
HVD-7.5%), but no differences were seen between the treatment
groups. The 3 month BMD still showed no significant changes
between the treatment groups. 1 month bone histomorphometric
parameters showed an increase for bone volume, osteoid volume
and trabecular number for the proximal tibia and distal femur with
increasing vitamin D treatment. The Mankin score showed a
significant increase in cartilage degeneration in the HVD MNX
leg compared to all other groups. All treatment groups showed
a significantly increased score on the MNX leg compared to
control. Histological results from Von-Kossa staining of the 1
month kidneys showed no significant differences between the
groups.
Conclusions: This study demonstrates that vitamin D intake has
an effect on cartilage and bone in OA. The effect of vitamin D
treatment may not be apparent on BMD 1 month after MNX, but
can be seen in bone histomorphometric properties with increas-
ing bone and osteoid. The increase in bone histomorphometric
properties may point to an increase in bone formation, but further
investigation of bone mineralization and microhardness must be
done to fully understand the effects of vitamin D on subchondral
bone. We also showed that the MNX guinea pig model is a
reliable model of OA, with decreases in BMD in the MNX leg and
increases in Mankin score. The high Mankin score in the HVD
group may mean that the dose given to the guinea pigs is too
high and a dose-response study should be investigated. Further
time points must still be looked at to fully understand the effect
of vitamin D on the bone and cartilage during the progression of
OA.
P136
IL-1 STIMULATES TWO SETS OF CHEMOKINES IN
NORMAL AND ADULT ADULT ARTICULAR
CHONDROCYTES
L.J. Sandell, X. Xing, C. Franz, D. Patra
Washington University, St. Louis, MO
Purpose: IL-1 is a proinflammatory cytokine present during
inflammatory reactions. In OA, IL-1 is present in the synovial
fluid and synthesized by synovial cells and chondrocytes. IL-
1 is known to increase catabolic activity of chondrocytes and
inhibit matrix gene expression. Recently, we have found that IL-1
stimulates the growth and differentiation factor BMP-2 in adult
articular chondrocytes, indicating that IL-1 also may activate a
repair process. These results lead us to hypothesize that IL-1
has many different effects on chondrocytes that may be depend
on time of exposure, concentration of cytokine and location in
